The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2019

Filed:

May. 04, 2016
Applicant:

Intelligent Synthetic Biology Center, Daejeon, KR;

Inventors:

Sun Chang Kim, Daejeon, KR;

Hun Sik Kim, Seoul, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A61P 35/02 (2006.01); A61K 31/704 (2006.01); A61K 45/06 (2006.01); A61K 31/506 (2006.01); A23L 33/125 (2016.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/704 (2013.01); A23L 33/125 (2016.08); A61K 31/506 (2013.01); A61K 31/70 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A23V 2002/00 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for preventing or treating Gleevec-resistant leukemia, containing, as an active ingredient, ginsenoside F1 or Rg3 which exhibits a preventive or therapeutic effect on Gleevec-resistant leukemia through enhancing cell killing activity of NK cells; a method for treating Gleevec-resistant leukemia comprising a step of administering the pharmaceutical composition; and a food composition for preventing or ameliorating Gleevec-resistant leukemia. Since the pharmaceutical composition of the present invention can effectively treat leukemia that exhibits resistance to conventional Gleevec, the pharmaceutical composition can be widely used for effective leukemia treatment.


Find Patent Forward Citations

Loading…